Ischemic and Peroxynitrite Preconditioning Effects in Chronic Hypoxic Rat Lung

Abstract

Chronic hypoxic pulmonary hypertension is characterized by vasoconstriction and vascular remodeling and impaired endothelial nitric oxide (NO) production. Although ischemic preconditioning of the lung leads to protective effect against ischemic reperfusion injury, the mechanisms of this protection are not well documented in the lung. The aim of this study was to investigate the effects of chronic hypoxia on preconditioning induced by ischemia or peroxynitrite in isolated rat lungs. The isolated rat lung, from exposed to hypobaric hypoxia for 21 days, was mounted on a modified Langendorff perfusion apparatus. Lungs were preconditioned by either 5 minutes' ischemia and 5 minutes' reperfusion or 10 microM peroxynitrite prior to 2 hours of normothermic ischemia. Although ischemia-reperfusion or peroxynitrite preconditioning markedly reduced KCl responses on perfusion pressure, phenylephrine-induced responses were not significantly modified. Pretreatment of the hypoxic lungs with peroxynitrite scavenger, uric acid, or poly (ADP-ribose) synthase inhibitors (PARS), 3-aminobenzamide (3-AB) or nicotinamide, did not modify the KCl- and phenylephrine-induced responses in chronic hypoxic lungs. There were also no marked differences either in wet to dry weight ratio or malondialdehyde levels of chronic hypoxic lungs. These results imply that preconditioning does not occur in the chronic hypoxic rat lungs.

Use of donors who have suffered cardiopulmonary arrest and resuscitation in lung transplantation☆

“…However, there are limited data on similar effects on the lung. In different animal models, it was found that IP, by blocking the pulmonary hilar blood flow, could attenuate the pulmonary dysfunction related to exposure to subsequent I/R [21].…”

Natural Compounds as Modulators of NADPH Oxidases

“…ONOO − is an oxidizing and nitrating molecule that has been implicated in cancer [13] and other acute [14] and chronic [15] diseases. ROS levels in tumor cells are controlled in a particular way, which stresses the importance of the development of novel ROS-targeted anticancer therapies.…”

Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets

“…Superoxide has been implicated in the pathology of many disease states, from cancer to cardiovascular disease, and is known to be able to damage DNA directly through oxidation, to inactivate cellular anti‐oxidants such as catalase and glutathione peroxidase and to activate proinflammatory nuclear factor‐ κ B . The reaction of superoxide with the NO radical is a critically important process that generates ONOO − , an oxidizing and nitrating agent that has been linked to the pathogenesis of cancer and other disease states . The ONOO − ‐induced oxidation of cysteine and nitration of tyrosine directly influences both the properties of proteins and cell signalling pathways, such as haemoglobin, inducible and endothelial NO synthases and Complexes I–IV of the electron transport chain.…”